Socinski MA - Search Results

1

Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.

Socinski MA, Smit EF, Lorigan P, Konduri K, Reck M, Szczesna A, Blakely J, Serwatowski P, Karaseva NA, Ciuleanu T, Jassem J, Dediu M, Hong S, Visseren-Grul C, Hanauske AR, Obasaju CK, Guba SC, Thatcher N. Socinski MA, et al. J Clin Oncol. 2009 Oct 1;27(28):4787-92. doi: 10.1200/JCO.2009.23.1548. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720897 Clinical Trial.

2

Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Long-term results.

Elias AD, Skarin AT, Gonin R, Oliynyk P, Stomper PC, O'Hara C, Socinski MA, Sheldon T, Maggs P, Frei E 3rd. Elias AD, et al. Among authors: socinski ma. Am J Clin Oncol. 1994 Feb;17(1):26-36. doi: 10.1097/00000421-199402000-00007. Am J Clin Oncol. 1994. PMID: 8311004 Clinical Trial.

3

Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.

Socinski MA, Detterbeck FC, Rivera MP, Egan TM, Halle J, Rosenman J. Socinski MA, et al. N C Med J. 1996 Sep-Oct;57(5):281-6. N C Med J. 1996. PMID: 8854691 Review. No abstract available.

4

High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.

Socinski MA, Shea TC. Socinski MA, et al. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-45-S12-51. Semin Oncol. 1997. PMID: 9331121 Review.

5

Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.

Socinski MA, Clark JA, Halle J, Steagall A, Kaluzny B, Rosenman JG. Socinski MA, et al. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-117-S12-122. Semin Oncol. 1997. PMID: 9331135 Clinical Trial.

6

Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: report of a phase II trial.

Socinski MA, Steagall A, Gillenwater H. Socinski MA, et al. Cancer Invest. 1999;17(3):181-8. doi: 10.3109/07357909909021419. Cancer Invest. 1999. PMID: 10099656 Clinical Trial.

7

Combined-modality therapy in the nonsurgical management of unresectable stage III non-small cell lung cancer.

Hensing TA, Socinski MA. Hensing TA, et al. Among authors: socinski ma. Curr Opin Pulm Med. 1999 Jul;5(4):194-200. doi: 10.1097/00063198-199907000-00003. Curr Opin Pulm Med. 1999. PMID: 10407686 Review.

8

Single-agent paclitaxel in the treatment of advanced non-small cell lung cancer.

Socinski MA. Socinski MA. Oncologist. 1999;4(5):408-16. Oncologist. 1999. PMID: 10551557 Free article.

9

The current status of adjuvant chemotherapy for resected non-small cell lung cancer.

Socinski MA. Socinski MA. Semin Oncol. 1999 Oct;26(5 Suppl 15):27-33. Semin Oncol. 1999. PMID: 10566608 Review.

10

Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer.

Socinski MA, Langer CJ. Socinski MA, et al. Semin Oncol. 1999 Oct;26(5 Suppl 16):51-61; discussion 71-2. Semin Oncol. 1999. PMID: 10585009 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

339 results

Search Page